Genedata Launches New Electronic Lab Notebook Integrated into Its Platform
Genedata, a Danaher company, has introduced an electronic lab notebook (ELN) that integrates directly into its existing biopharmaceutical R&D platform.
Stocks · News reference
Danaher Officer Files Form 144 for Stock Sale
Danaher Corporation officer Matthew McGrew filed a Form 144 to propose the sale of 29,754 shares of common stock.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Evercore ISI Adjusts Price Target on Danaher to $205 From $242
Evercore ISI has revised its price target for Danaher Corporation, lowering it from $242 to $205.
Danaher (DHR) Upgraded to Buy: Here's Why
Danaher (DHR) has been upgraded to a Zacks Rank #2 (Buy) rating, reflecting upward trends in earnings estimates. The industrial and medical device maker's consensus estimate for fiscal year 2026 shows a 0.8% increase over the past three months. The upgrade positions Danaher in the top 20% of Zacks-covered stocks, suggesting potential for near-term stock price appreciation driven by improving business fundamentals.